Beacon Financial Group Has $128,000 Stock Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Beacon Financial Group cut its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 46.6% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 13,756 shares of the pharmacy operator’s stock after selling 12,017 shares during the period. Beacon Financial Group’s holdings in Walgreens Boots Alliance were worth $128,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the business. State Street Corp increased its stake in Walgreens Boots Alliance by 18.0% in the 3rd quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator’s stock valued at $385,258,000 after buying an additional 6,569,223 shares during the last quarter. Charles Schwab Investment Management Inc. increased its position in shares of Walgreens Boots Alliance by 43.6% in the third quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator’s stock valued at $98,284,000 after acquiring an additional 3,329,857 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in Walgreens Boots Alliance by 12.1% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 7,594,475 shares of the pharmacy operator’s stock worth $68,046,000 after acquiring an additional 817,762 shares in the last quarter. Thompson Siegel & Walmsley LLC boosted its position in Walgreens Boots Alliance by 15.5% during the third quarter. Thompson Siegel & Walmsley LLC now owns 6,955,880 shares of the pharmacy operator’s stock valued at $62,325,000 after purchasing an additional 934,754 shares during the last quarter. Finally, FMR LLC grew its stake in Walgreens Boots Alliance by 2.5% in the third quarter. FMR LLC now owns 3,258,919 shares of the pharmacy operator’s stock valued at $29,200,000 after purchasing an additional 80,525 shares in the last quarter. Institutional investors own 58.59% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently commented on the company. Evercore ISI increased their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a report on Monday, January 13th. Barclays increased their price target on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a research note on Wednesday, October 16th. Jefferies Financial Group lowered their price objective on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating on the stock in a research note on Wednesday, October 23rd. Truist Financial cut their target price on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a research note on Friday, January 31st. Finally, Bank of America boosted their price target on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a research report on Monday, January 13th. Four investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $13.19.

Walgreens Boots Alliance Stock Up 1.2 %

WBA opened at $9.47 on Thursday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. The business has a fifty day simple moving average of $10.25 and a 200 day simple moving average of $9.77. Walgreens Boots Alliance, Inc. has a 1 year low of $8.08 and a 1 year high of $22.55.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The company had revenue of $39.50 billion during the quarter, compared to analysts’ expectations of $37.40 billion. During the same quarter in the previous year, the business posted $0.66 earnings per share. Walgreens Boots Alliance’s quarterly revenue was up 7.6% on a year-over-year basis. Equities analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.